Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 4 | 2022 | 83 | 1.830 |
Why?
|
| Laparoscopy | 5 | 2020 | 237 | 1.680 |
Why?
|
| Telemedicine | 5 | 2022 | 700 | 1.650 |
Why?
|
| Hernia, Inguinal | 3 | 2020 | 21 | 1.580 |
Why?
|
| Enterocolitis, Necrotizing | 3 | 2022 | 37 | 1.560 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 581 | 1.010 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2022 | 91 | 0.920 |
Why?
|
| Enteral Nutrition | 3 | 2022 | 157 | 0.890 |
Why?
|
| Infant | 14 | 2022 | 2891 | 0.810 |
Why?
|
| Infant, Newborn | 10 | 2022 | 2455 | 0.740 |
Why?
|
| Anesthesia, Spinal | 1 | 2020 | 16 | 0.730 |
Why?
|
| Anesthesia, Conduction | 1 | 2020 | 14 | 0.720 |
Why?
|
| Smartphone | 1 | 2021 | 69 | 0.720 |
Why?
|
| Intestinal Volvulus | 2 | 2010 | 4 | 0.710 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 124 | 0.700 |
Why?
|
| Colon | 2 | 2011 | 168 | 0.690 |
Why?
|
| Remote Consultation | 1 | 2019 | 50 | 0.650 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2018 | 1 | 0.650 |
Why?
|
| Pyloric Stenosis | 1 | 2018 | 5 | 0.650 |
Why?
|
| Pylorus | 1 | 2018 | 6 | 0.640 |
Why?
|
| Biomedical Technology | 1 | 2018 | 14 | 0.640 |
Why?
|
| Home Care Services | 1 | 2018 | 84 | 0.600 |
Why?
|
| Perioperative Care | 1 | 2018 | 100 | 0.570 |
Why?
|
| Rural Health Services | 1 | 2018 | 101 | 0.560 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2016 | 7 | 0.560 |
Why?
|
| Diaphragmatic Eventration | 1 | 2016 | 9 | 0.560 |
Why?
|
| Child | 13 | 2022 | 6405 | 0.550 |
Why?
|
| Mobile Applications | 1 | 2018 | 138 | 0.540 |
Why?
|
| Infant, Premature | 4 | 2022 | 284 | 0.540 |
Why?
|
| Ambulatory Care | 1 | 2018 | 340 | 0.540 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 109 | 0.520 |
Why?
|
| Humans | 34 | 2022 | 68618 | 0.470 |
Why?
|
| Primary Health Care | 1 | 2019 | 703 | 0.450 |
Why?
|
| Retrospective Studies | 12 | 2022 | 7277 | 0.420 |
Why?
|
| Recurrence | 5 | 2020 | 948 | 0.420 |
Why?
|
| Occlusive Dressings | 1 | 2011 | 7 | 0.400 |
Why?
|
| Hirschsprung Disease | 1 | 2011 | 4 | 0.390 |
Why?
|
| beta-Glucans | 1 | 2011 | 18 | 0.390 |
Why?
|
| Catheters, Indwelling | 2 | 2008 | 72 | 0.380 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2011 | 54 | 0.380 |
Why?
|
| Robotics | 1 | 2011 | 56 | 0.370 |
Why?
|
| Catheterization, Central Venous | 2 | 2008 | 89 | 0.370 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 3 | 0.370 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2010 | 5 | 0.370 |
Why?
|
| Teratoma | 1 | 2010 | 22 | 0.360 |
Why?
|
| Defecography | 1 | 2010 | 3 | 0.360 |
Why?
|
| Rectal Prolapse | 1 | 2010 | 5 | 0.360 |
Why?
|
| Sigmoid Diseases | 1 | 2010 | 8 | 0.360 |
Why?
|
| Encephalitis | 1 | 2010 | 43 | 0.360 |
Why?
|
| Intestinal Obstruction | 1 | 2010 | 36 | 0.360 |
Why?
|
| Omentum | 1 | 2010 | 18 | 0.350 |
Why?
|
| Constipation | 1 | 2010 | 32 | 0.350 |
Why?
|
| Infant, Premature, Diseases | 2 | 2021 | 85 | 0.350 |
Why?
|
| Abdominal Pain | 1 | 2010 | 97 | 0.330 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 267 | 0.320 |
Why?
|
| Collagen | 1 | 2011 | 636 | 0.310 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 266 | 0.310 |
Why?
|
| Specialties, Surgical | 2 | 2018 | 19 | 0.300 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 3259 | 0.300 |
Why?
|
| Herniorrhaphy | 2 | 2020 | 38 | 0.300 |
Why?
|
| Device Removal | 1 | 2008 | 100 | 0.290 |
Why?
|
| Equipment Design | 1 | 2008 | 500 | 0.280 |
Why?
|
| Spleen | 2 | 2009 | 301 | 0.270 |
Why?
|
| Animals, Wild | 1 | 2006 | 18 | 0.270 |
Why?
|
| Treatment Outcome | 6 | 2020 | 7029 | 0.270 |
Why?
|
| Interleukin-4 | 1 | 2006 | 69 | 0.270 |
Why?
|
| Male | 12 | 2020 | 37321 | 0.260 |
Why?
|
| Antibodies, Heterophile | 1 | 2005 | 11 | 0.260 |
Why?
|
| Child, Preschool | 6 | 2018 | 3187 | 0.250 |
Why?
|
| Pediatrics | 2 | 2018 | 341 | 0.240 |
Why?
|
| Adolescent | 7 | 2019 | 8912 | 0.240 |
Why?
|
| Wound Healing | 2 | 2018 | 260 | 0.220 |
Why?
|
| Female | 13 | 2022 | 38074 | 0.210 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 597 | 0.200 |
Why?
|
| Catheterization, Peripheral | 1 | 2022 | 38 | 0.190 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2022 | 69 | 0.190 |
Why?
|
| Outpatients | 1 | 2022 | 127 | 0.190 |
Why?
|
| Consensus | 1 | 2022 | 211 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2020 | 2358 | 0.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 123 | 0.180 |
Why?
|
| Escherichia coli K12 | 2 | 2010 | 9 | 0.180 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 113 | 0.170 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 58 | 0.170 |
Why?
|
| Biliary Dyskinesia | 1 | 2019 | 7 | 0.170 |
Why?
|
| Medically Underserved Area | 1 | 2019 | 85 | 0.160 |
Why?
|
| Lung Transplantation | 3 | 2006 | 88 | 0.160 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2019 | 101 | 0.160 |
Why?
|
| Medically Uninsured | 1 | 2019 | 99 | 0.160 |
Why?
|
| Pandemics | 1 | 2022 | 352 | 0.160 |
Why?
|
| Videoconferencing | 1 | 2018 | 43 | 0.160 |
Why?
|
| Text Messaging | 1 | 2018 | 47 | 0.150 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 168 | 0.150 |
Why?
|
| Quality Improvement | 1 | 2022 | 413 | 0.150 |
Why?
|
| Rats | 1 | 2006 | 5300 | 0.150 |
Why?
|
| Fluoroscopy | 1 | 2018 | 152 | 0.150 |
Why?
|
| Aftercare | 1 | 2018 | 114 | 0.140 |
Why?
|
| Reoperation | 1 | 2018 | 467 | 0.140 |
Why?
|
| Linear Models | 1 | 2018 | 521 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 378 | 0.130 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.120 |
Why?
|
| Hospitalization | 1 | 2020 | 978 | 0.120 |
Why?
|
| Logistic Models | 1 | 2018 | 1420 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 711 | 0.120 |
Why?
|
| South Carolina | 1 | 2019 | 2752 | 0.100 |
Why?
|
| Epitopes | 2 | 2009 | 146 | 0.100 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2010 | 4 | 0.090 |
Why?
|
| Retroviridae | 1 | 2010 | 29 | 0.090 |
Why?
|
| Gastrostomy | 2 | 2021 | 110 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 63 | 0.090 |
Why?
|
| Genetic Engineering | 2 | 2010 | 41 | 0.090 |
Why?
|
| Intestine, Large | 1 | 2009 | 2 | 0.090 |
Why?
|
| Cancer Vaccines | 1 | 2010 | 61 | 0.090 |
Why?
|
| Splenic Diseases | 1 | 2009 | 10 | 0.080 |
Why?
|
| Papio | 3 | 2006 | 27 | 0.080 |
Why?
|
| Appendicitis | 1 | 2010 | 55 | 0.080 |
Why?
|
| Superoxides | 1 | 2009 | 70 | 0.080 |
Why?
|
| Splenectomy | 1 | 2009 | 40 | 0.080 |
Why?
|
| Video Recording | 1 | 2010 | 145 | 0.080 |
Why?
|
| Melanoma | 2 | 2010 | 335 | 0.080 |
Why?
|
| Transplantation, Heterologous | 3 | 2006 | 122 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2009 | 79 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2010 | 132 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 135 | 0.080 |
Why?
|
| Short Bowel Syndrome | 1 | 2008 | 15 | 0.080 |
Why?
|
| Equipment Safety | 1 | 2008 | 50 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 397 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2008 | 53 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 226 | 0.080 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 39 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2008 | 112 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 266 | 0.070 |
Why?
|
| Swine | 3 | 2006 | 672 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 307 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2008 | 163 | 0.070 |
Why?
|
| Adult | 2 | 2022 | 21403 | 0.070 |
Why?
|
| Complement C5a | 1 | 2006 | 15 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1140 | 0.070 |
Why?
|
| Concanavalin A | 1 | 2006 | 22 | 0.070 |
Why?
|
| Rats, Inbred WKY | 1 | 2006 | 48 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 40 | 0.070 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 104 | 0.070 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 150 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2006 | 511 | 0.070 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2002 | 9 | 0.070 |
Why?
|
| Animals | 7 | 2010 | 20881 | 0.060 |
Why?
|
| Antibody Specificity | 1 | 2005 | 98 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2006 | 133 | 0.060 |
Why?
|
| United States | 1 | 2018 | 7367 | 0.060 |
Why?
|
| Carbohydrates | 1 | 2005 | 57 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2009 | 364 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1330 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2008 | 2007 | 0.060 |
Why?
|
| Drug Contamination | 1 | 2003 | 10 | 0.060 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 18 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.060 |
Why?
|
| Hemostatics | 1 | 2003 | 47 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 626 | 0.060 |
Why?
|
| Thrombin | 1 | 2003 | 117 | 0.050 |
Why?
|
| von Willebrand Factor | 1 | 2002 | 47 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2006 | 458 | 0.050 |
Why?
|
| Cannula | 1 | 2022 | 4 | 0.050 |
Why?
|
| Ethanol | 1 | 2008 | 893 | 0.050 |
Why?
|
| Reperfusion | 1 | 2022 | 78 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2002 | 284 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2022 | 110 | 0.050 |
Why?
|
| Femoral Artery | 1 | 2022 | 139 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 2083 | 0.050 |
Why?
|
| Ischemia | 1 | 2022 | 229 | 0.050 |
Why?
|
| Gestational Age | 1 | 2021 | 389 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2022 | 153 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2019 | 18 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 75 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 36 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2324 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 236 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 51 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 145 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2019 | 87 | 0.040 |
Why?
|
| Gallbladder | 1 | 2019 | 15 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2019 | 129 | 0.040 |
Why?
|
| Cholecystectomy | 1 | 2019 | 79 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 193 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 294 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 47 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2020 | 267 | 0.040 |
Why?
|
| Mentoring | 1 | 2018 | 53 | 0.040 |
Why?
|
| Length of Stay | 1 | 2020 | 780 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 619 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 866 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 378 | 0.030 |
Why?
|
| Needles | 1 | 2014 | 34 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 45 | 0.030 |
Why?
|
| Blood Coagulation | 2 | 2006 | 123 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 772 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2002 | 50 | 0.030 |
Why?
|
| Mice | 3 | 2010 | 8474 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2800 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 1515 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2010 | 85 | 0.020 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2010 | 3 | 0.020 |
Why?
|
| Immunomagnetic Separation | 1 | 2010 | 5 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 81 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 75 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2009 | 6 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2009 | 18 | 0.020 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2009 | 6 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 89 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2009 | 10 | 0.020 |
Why?
|
| Fimbriae, Bacterial | 1 | 2009 | 13 | 0.020 |
Why?
|
| Adhesins, Bacterial | 1 | 2009 | 13 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2009 | 25 | 0.020 |
Why?
|
| Probiotics | 1 | 2009 | 14 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2009 | 38 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2009 | 33 | 0.020 |
Why?
|
| Cecum | 1 | 2009 | 39 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 181 | 0.020 |
Why?
|
| Feces | 1 | 2009 | 88 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2009 | 91 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2009 | 112 | 0.020 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 329 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 376 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 219 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 2008 | 38 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1054 | 0.020 |
Why?
|
| Endothelium | 1 | 2006 | 98 | 0.020 |
Why?
|
| Sepsis | 1 | 2009 | 233 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1864 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14862 | 0.010 |
Why?
|
| Disaccharides | 1 | 2003 | 9 | 0.010 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2003 | 17 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1174 | 0.010 |
Why?
|
| Graft Survival | 1 | 2006 | 465 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2002 | 7 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2002 | 127 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 99 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 2002 | 24 | 0.010 |
Why?
|
| Antithrombin III | 1 | 2002 | 23 | 0.010 |
Why?
|
| Platelet Count | 1 | 2002 | 100 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2002 | 82 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 507 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2002 | 87 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 21147 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 1451 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5717 | 0.010 |
Why?
|
| Lung | 1 | 2002 | 849 | 0.010 |
Why?
|